CIK 0001043961
- Non-accelerated filer
- Smaller reporting company
Precipio, Inc.
Sign in to watch- Ticker
- PRPO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911789357
- Phone
- +1 203-787-7888
- Business address
- 4 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- TRANSGENOMIC INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-01-14 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +4,000 | 4,000 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −166 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +166 | 166 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −133 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +133 | 133 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −375 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +375 | 375 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −400 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400 | 400 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −500 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +500 | 500 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −1,250 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,250 | 1,250 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −1,000 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2024-06-21 | Gage Matthew CFO | Grant or award · Stock Option (Right to Buy) | +4,000 | 4,000 | ||
| 2023-01-06 | Gage Matthew See Remark | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 1 of 1 · 18 trades